Results of the American College of Surgeons Oncology Group Z0050 Trial: The utility of positron emission tomography in staging potentially operable non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 6, 2003, Pages 1943-1951

  Reed, Carolyn E ^a   Harpole, David H ^b   Posther, Katherine E ^c   Woolson, Sandra L ^c   Downey, Robert J ^d   Meyers, Bryan F ^e   Heelan, Robert T ^d   MacApinlac, Homer A ^f   Jung, Sin Ho ^c   Silvestri, Gerard A ^g   Siegel, Barry A ^h   Rusch, Valerie W ^d   Cerfolio, Robert J ⁱ   Detterbeck, Frank C ⁱ  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; UTILIZATION REVIEW;

EID: 9144245702     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.07.030     Document Type: Article

References (26)

1. Gould MK, MacLean CC, Kuschner WG, Rydzak CE, Owen DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001;285:914-24.
2. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer. Chest. 2003;123:137S-46S.
3. Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of non-small cell lung cancer. The guidelines. Chest. 2003;123:147S-56S.
4. Pieterman RM, van Putten JWG, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, et al. Preoperative staging of non-small cell lung cancer with positron emission tomography. N Engl J Med. 2000;343:254-61.
5. Van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JAHM, Schreurs AJM, Stallaert RALM, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small cell lung cancer: the PLUS multicentre randomised trial. Lancet. 2002:359:1388-92.
6. Simon R. Optimal two-stage designs for phase 11 clinical trials. Control Clin Trials. 1989;10:1-10.
7. Jennison C, Turnbull BW. Confidence intervals for a binomial parameter following a multistage test with application to MIL-STD 105D and medical trials. Technometrics. 1983:25:49-58.
8. Jung SH, Kim KM. On the estimation of the binomial probability in multistage clinical trials. Stat Med. (in press).
9. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analysis comparison of PET and CT. Radiology. 1999;213:530-6.
10. Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch CM. Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000. Pneumologie. 2001;55:367-77.
11. Stroobants S, Verschakelen J, Vansteenkiste J. Value of FDG-PET in the management of non-small cell lung cancer. Eur J Radiol. 2003;45:47-59.
12. Gonzalez-Stawinski GV, Lemaire A, Merchant FM, O'Halloran EK, Coleman RE, Harpole DH, et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:1900-5.
13. Roberts PF, Follette DM, von Haag D, Park JA, Valk PE, Pounds TR, et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 2000:70:1154-60.
14. Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest. 2001;120:521-7.
15. Kerstine KH, McLaughlin KA, Menda Y, Rossi NP, Kohn DJ, Bushnell DL, et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable non-small cell lung cancer? Ann Thorac Surg. 2002;73:394-402.
16. Vesselle H, Pugsley JM, Vallières E, Wood DE. The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;124:511-9.
17. Graeter TP, Hellwig D, Hoffman K, Ukena D, Kirsch C-M, Schäfers H-J. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg. 2003;75:231-6.
18. Griffeth LK, Rich KM, Dehdashti F, Simpson JR, Fusselman MJ, McGuire AH, et al. Brain metastases from non-central nervous system tumors: evaluation with PET. Radiology 1993;186:37-44.
19. Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, et al. Staging non-small cell lung cancer with whole body PET. Radiology. 1999;212:803-9.
20. Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P. Fluorine- 18-deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med. 1998;25:1244-7.
21. Erasmus JJ, Patz EF, McAdams HP, Murray JG, Herndon J, Coleman RE, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol. 1997;168:1357-60.
22. Boland GW, Goldberg MA, Lee MJ, Mayo-Smith WW, Dixon J, McNicholas MM, et al. Indeterminate adrenal mass in patients with cancer: evaluation of PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1995;194:131-4.
23. Yun M, Kim W, Alnafisi N, LaCorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl. Med. 2001;42:1795-9.
24. Weder W, Schmid RA, Bruckhaus H, Hillinger S, von Schulthess GK, Steinert HC. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Am Thorac Surg. 1998:66:886-93.
25. Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, et al. Staging non-small cell lung cancer by whole-body positron emission tomography imaging. Ann Thorac Surg. 1995;60:1573-81.
26. Lardinois D, Weder W, Hany TF, Karmel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500-7.